Status:
COMPLETED
Induction of Migraine Aura With Cilostazol
Lead Sponsor:
Herlev Hospital
Conditions:
Migraine With Aura
Stroke
Eligibility:
All Genders
18-50 years
Phase:
EARLY_PHASE1
Brief Summary
In a double blind placebo-controlled cross-over study the effect of cilostazol on aura induction and endothelial response is tested in patient with migraine with aura.
Detailed Description
Migraine with aura is associated to an increased risk of stroke. The mechanism behind such increased risk is not fully understood. Cilostazol induce headache and migraine in migraine patients and is u...
Eligibility Criteria
Inclusion
- Migraine with aura
- Minimum of 2 attacks/year
Exclusion
- Chronic tension type headache
- Cardiac arrhythmias
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02253004
Start Date
September 1 2014
End Date
August 1 2015
Last Update
August 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital, Dept Neurology
Herlev, Denmark, 2730